معرفی
Tomas Weitoft is an Associate Professor at the Center for Clinical Research, Gävleborg, affiliated with Uppsala University. His academic career focuses on clinical research in rheumatology with particular expertise in rheumatoid arthritis pathophysiology and treatment.
Dr. Weitoft's research interests include:
- Immunological mechanisms in rheumatoid arthritis
- Biomarkers for disease activity and progression (exhaled nitric oxide, calprotectin, autoantibodies)
- Effects of conventional treatments including methotrexate and intra-articular glucocorticoids
- Autoantibody profiles and their clinical significance in RA subtypes
- Novel diagnostic approaches for early rheumatoid arthritis
His publication record from 2015-2024 reveals a consistent research trajectory examining the relationship between immunological markers and clinical outcomes in rheumatoid arthritis. Recent work has particularly focused on exhaled nitric oxide as a biomarker for airway inflammation in early RA, calprotectin correlations with disease activity in ACPA-positive patients, and the prognostic value of secretory antibodies.
Dr. Weitoft has maintained productive collaborations with researchers at Uppsala University and Region Gävleborg, contributing to numerous clinical studies on treatment optimization for knee synovitis and investigating complementary approaches to managing treatment side effects.
